Tumor markers for liver lesions, including alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9), were nonremarkable. This evidence concerns the gene CEACAM5 and neoplasm.